Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Chemotherapy (Florence, Italy)|February 14, 2024
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypesAnil Yıldiz, Ahmet Bilici, Ozgur Acikgoz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021
Prognostic significance of primary tumor localization in patients with metastatic colorectal cancer: Is it beneficial to select targeted treatment? Real-life experience from TurkeyBurcin Cakan, Ozgur Acikgoz, Ahmet Bilici, et al.
Medicine|December 6, 2021
Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancerOzgur Acikgoz, Burcin Cakan, Tarik Demir, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2023
Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamideSabin Goktas Aydin, Yasin Kutlu, Harun Muglu, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Impact of Adjuvant Gemcitabine Containing Chemotherapy Following Radical Nephroureterectomy for Patients with Upper Tract Urothelial Carcinoma: Results from a Propensity-Score Matched Cohort StudyZhao Hongda, Liu Kang, Chi-Fai Ng, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 23, 2026
Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastomaEmirhan Harbi, Yasemin Yozgat Byrne, Hamza Ugur Bozbey, et al.
Oncology Research and Treatment|March 15, 2019
Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative GastrectomyAhmet Bilici, Fatih Selcukbiricik, Mesut Seker, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) StudyZiya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Cancers|October 16, 2024
Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group StudyEbru Karci, Ahmet Bilici, Buket Bayram, et al.
Pageof 3